NCT06524830
ClinicalTrials.gov
- Trial ID
- T-ctgov-NCT06524830
- Registry
- ClinicalTrials.gov
- NCT number
- NCT06524830
- Asset
- VLS-01
- Sponsor, as registered
- atai Therapeutics, Inc.
- Phase
- PHASE2
- Indication
- Treatment Resistant Depression
- Status
- COMPLETED
- Start date
- 2024-12-30
- Primary completion
- 2026-07-30
- Registered countries
- Australia, Canada, United Kingdom, United States
- Sites
- 48
The sponsor's registered location list, which states intent rather than approval.
clinicaltrials.govctgov registryverified 2026-11-02
Notes on the record
Supersedes the row verified 2026-10-26 (kept), per DATA LAYER rule 4. Changed: overall_status RECRUITING to COMPLETED, primary_completion_date 2026-08-01 ESTIMATED to 2026-07-30 ACTUAL. Read from the ClinicalTrials.gov v2 API record on 2026-11-02: last update posted 2026-10-30; study completion 2026-10-16 ACTUAL (was 2026-08-30); enrollment 142 ACTUAL; hasResults false; countries and site_count (48 location entries) unchanged. The collector proposed the same change on 2026-10-31 (inbox/proposed-rows/2026-10-31-trials.csv, confidence reported); this row is from the 2026-11-02 read.
Company
Through VLS-01: atai Therapeutics
Cited in
Issues quoting NCT06524830 in their own text.